Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma [Phase 1]

View source ↗

Summary

This clinical trial update reports completed Phase 1 results evaluating a monoclonal antibody therapy in patients with recurrent or refractory lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma | Phase 1 | Status: COMPLETED